Managing cholera as a preventable global threat

Journal of Vaccines and Vaccination

Volumn 4, Issue 3, 2013, Pages

  Thompson, Kimberly M ^a,b   Duintjer Tebbens, Radboud J ^b   Chaignat, Claire Lise ^c   Hill, Alexandra ^c   Badizadegan, Kamran ^a,d   Costa, Alejandro J ^c   Namgyal, Pem ^c   Hutubessy, Raymond C ^c  

^a Kid Risk Inc   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d NEMOURS CHILDREN S HOSPITAL   (United States)

Author keywords

Cholera; Global tragedy; Oral cholera vaccines

Indexed keywords

EID: 84879930204     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000183     Document Type: Review

References (44)

1. Colwell RR (1996) Global climate change and infectious disease: The cholera paradigm. Science 274: 2025-2031.
2. Nelson EJ, Harris JB, Morris JG, Calderwood SB, Camilli A (2009) Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol 9: 673-702.
3. Bhattacharya S, Black R, Bourgeois L, Clemens J, Cravioto A, et al. (2009) The cholera crisis in Africa. Science 324: 885.
4. Klein E (1894) Cholera. Nature 49: 492-495.
5. Hirschhorn N, Greenough WB (1971) Cholera. Scientific American 225:15-21.
6. World Health Organization (2012) Cholera, 2011. Wkly Epidemiol Rec 87: 289-304.
7. Ali M, Lopez AL, You YA, Kim YE, Sah B, et al. (2012) The global burden of cholera. Bull World Health Organ 90: 209-218.
8. Enserink M (2012) Policy shifts on emergency use of cholera vaccines. Science 337: 785-786.
9. World Health Organization (2012) Technical working group on creation of an oral cholera vaccine stockpile. Report number WHO/HSE/PED/2012.2.
10. World Health Organization (1999) Potential use of oral cholera vaccines in emergency situations. Report number WHO/CDS/CSR/EDC/99.4.
11. Clemens J, Shin S, Sur D, Nair GB, Holmgren J (2011) New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol 8: 701-710.
12. World Health Organization, Global Task Force on Cholera Control (2002) Cholera vaccines: A new public health tool? Report number WHO/CDS/CPE/ZFK/2004.5.
13. World Health Organization (2005) Use of the two-dose oral cholera vaccine in the context of a major natural disaster. Report number WHO/CDS/NTD/IDM/2006.1.
14. World Health Organization, Global Task Force on Cholera Control (2005) Oral cholera vaccine use in complex emergencies: What next? Report number WHO/CDS/NTD/IDM/2006.2.
15. World Health Organization (2011) WHO Consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options. Report number WHO/IVB/12.05
16. Waldor MK, Hotez PJ, Clemens JD (2010) A national cholera vaccine stockpile--a new humanitarian and diplomatic resource. N Engl J Med 363: 2279-2282.
17. Clemens JD (2011) Vaccines in the time of cholera. Proc Natl Acad Sci U S A 108: 8529-8530.
18. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, et al. (2011) Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Emerg Infect Dis 17: 2105-2112.
19. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, et al. (2011) The case for reactive mass oral cholera vaccinations. Emerg Infect Dis 5: e952.
20. Chao DL, Halloran ME, Longini IM Jr (2011) Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings Proc Natl Acad Sci U S A 108: 7081-7085.
21. Tuite AR, Tien J, Eisenberg M, Earn DJ, Ma J, et al. (2011) Cholera epidemic in Haiti, 2010: Using a transmission model to explain spatial spread of disease and identify optimal control interventions. Ann Intern Med 154: 593-601.
22. Andrews JR, Basu S (2011) Transmission dynamics and control of cholera in Haiti: An epidemic model. Lancet 377: 1248-1255.
23. Bertuzzo E, Mari L, Righetto L, Gatto M, Casagrandi R, et al. (2011) Prediction of the spatial evolution and effects of control measures for the unfolding Haiti cholera outbreak. Geophys Res Let 38: L06403.
24. World Health Organization (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117-128.
25. Grais RF, Conlan AJK, Ferrari MJ, Djibo A, Le Menach A, et al. (2008) Time is of the essence: Exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface 5: 67-74.
26. Thompson KM, Duintjer Tebbens RJ, Pallansch MA (2006) Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal 26: 1541-1556.
27. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: A reanalysis. Lancet 366: 44-49.
28. Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, et al. (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22: 2444-2451.
29. Chaignat CL, Monti V (2007) Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr 25: 244-261.
30. Chaignat CL, Monti V, Soepardi J, Petersen G, Sorensen E, et al. (2008) Cholera in disasters: do vaccines prompt new hopes? Expert Rev Vaccines 7: 431-435.
31. Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, et al. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335: 270-273.
32. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, et al. (2005) Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352: 757-767.
33. Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, et al. (2008) A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One 3: e2323.
34. Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, et al. (1998) Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: A cost-effectiveness analysis. JAMA 279: 521-525.
35. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, et al. (2009) Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: An interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374: 1694-1702.
36. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, et al. (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4: e336.
37. Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, et al. (2012) Effectiveness of an oral cholera vaccine in Zanzibar, East Africa: Findings from a large mass vaccination campaign followed by an observational cohort study. Lancet Infect Dis 12: 837-844.
38. Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, et al. (2011) Estimating the reproductive numbers for the 2008-2009 cholera outbreaks in Zimbabwe. Proc Natl Acad Sci U S A 108: 8767-8772.
39. Hutton G, Haller L, Bartram J (2007) Global cost-benefit analysis of water supply and sanitation interventions. J Water Health 5: 481-502.
40. Jeuland M, Whittington D (2009) Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs. Vaccine 27: 3109-3120.
41. Miller Neilan RL, Schaefer E, Gaff H, Fister RK, Lenhart S (2010) Modeling optimal intervention strategies for cholera. Bull Math Biol 72: 2004-2018.
42. Schaetti C, Weiss MG, Ali SM, Chaignat C-L, Khatib AM, et al. (2012) Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar. PLoS Negl Trop Dis 26: e1844.
43. World Health Assembly (2011) Cholera: Mechanism for control and prevention (resolution 64.15).
44. Global Vaccine Action Plan 2011-2020.